Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
The BDNF Val(66)Met x 5-HTTLPR x child adversity interaction and depressive symptoms: An attempt at replication.
|
17579366 |
2008 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
The BDNF Val66Met polymorphism was examined in DNA samples from the mothers and daughters, and measures of depressive symptoms and rumination were also obtained.
|
17959306 |
2007 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
In addition, BDNF Val66Met and 5-HTTLPR polymorphisms seemed to moderate the effect of CSA on adult depressive symptoms.
|
19215635 |
2009 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
The low activity variants of the 5-HTT-linked polymorphic region in the serotonin transporter gene and the Met-allele of a single nucleotide polymorphism (Val66Met) in the gene encoding brain derived neurotrophic factor were independently associated with the presence of stressful life events prior to onset of depression, also when corrected for the effect of age, gender, marital status, personality disorder, neuroticism, and severity of depressive symptoms at the time of interview.
|
19339052 |
2009 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
Eighty-two healthy adolescent girls were genotyped for the BDNF val66met polymorphism, and their depressive symptoms and physical activity were assessed using questionnaires.
|
20230085 |
2010 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
The serotonin transporter polymorphism (5-HTTLPR) and the brain-derived neurotrophic factor (BDNF) val66met polymorphism have both been linked to depression symptoms and to depression diagnosis (MDD) in interaction with adversity; there have also been failures to find the effects.
|
21420735 |
2011 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
We found that the BDNF rs6265 polymorphism was related to the severity of depressive symptoms, and that this association was independent of neurotransmitter levels.
|
21898033 |
2012 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
The frequency of stressful life events was significantly correlated with depressive symptoms (twin1: β = 0.21, P = 0.01; twin2: β = 0.27, P < 0.01), but there was no significant main effect of the BDNF Val66Met genotype on depressive symptoms.
|
22931410 |
2012 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
BDNF Val 66 Met and 5-HTTLPR genotype moderate the impact of early psychosocial adversity on plasma brain-derived neurotrophic factor and depressive symptoms: a prospective study.
|
23058261 |
2013 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
Brain-derived neurotrophic factor (BDNF) Val66Met and adulthood chronic stress interact to affect depressive symptoms.
|
23140671 |
2013 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
The BDNF val66met polymorphism was independently associated with prevalent PSD, but not with persistent and incident PSD nor with depressive symptoms severity.
|
23399480 |
2013 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
Both 5-HTTLPR and BDNF Val66Met interacted with unfavourable environment in relation to depressive symptoms (Adj R²=0.19).
|
23481907 |
2013 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
Furthermore, the BDNF Val66Met polymorphism is a significant factor influencing the severity of anxiety/depression symptoms in schizophrenic patients.
|
23532065 |
2013 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
The Role of the Val66Met Polymorphism of the Brain Derived Neurotrophic Factor Gene in Coping Strategies Relevant to Depressive Symptoms.
|
23824678 |
2013 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
We conclude that the BDNF Val66Met polymorphism influenced responses to add-on memantine by decreasing depressive symptoms in patients with BP-II.
|
24103632 |
2014 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
In midlife, the BDNF Val66Met polymorphism neither attenuates nor magnifies the effect of physical activity on depressive symptoms.
|
24745471 |
2014 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
We modeled the interactive effects of peer victimization with three genetic polymorphisms (on 5-HTTLPR, DRD2 TaqIA, and BDNF Val66Met) on depressive symptoms.
|
24819687 |
2015 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
The present study has provided the first examination of whether working memory capacity, the BDNF Val66Met polymorphism, and their interaction predict changes in symptoms of depression during the transition to university.
|
24920443 |
2015 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
The current study examined the effects of val66met, 5-HTTLPR, and family environment quality on youth depressive symptoms in adolescence and young adulthood in a longitudinal sample oversampled for maternal depression history.
|
25347540 |
2014 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
This study represents the first replication of the BDNF Val66Met ⁎ 5-HTTLPR ⁎ childhood maltreatment effect on self-reported depression symptoms using a rigorous maltreatment interview.
|
26070769 |
2015 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
Results indicated the BDNF Val66Met polymorphism significantly moderated the influence of maternal warmth-reasoning, but not harshness-hostility, on youth depressive symptoms.
|
26510938 |
2016 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
There was a significant interaction between C-reactive protein (CRP) and the BDNF Val66met polymorphism in predicting cognitive depressive symptoms (p=.004), such that higher CRP was related to more cognitive depressive symptoms among Met allele carriers, but not among Val/Val homozygotes.
|
26967918 |
2016 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
Our investigation assessed whether indices of white matter integrity, serotonin transporter-linked polymorphism (5-HTTLPR) and brain-derived neurotrophic factor (BDNF) val66met polymorphism predicted magnitude of depression symptom change following antidepressant treatment.
|
27277475 |
2017 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
A BDNF Val66Met × Harsh Parenting interaction predicted the rise in depressive symptoms across a 3-year period, whereas a 5-HTTLPR × Harsh Parenting interaction predicted greater frequency in elevated depressive symptoms.
|
27736236 |
2018 |
Depressive Symptoms
|
|
0.100 |
GeneticVariation
|
BEFREE |
Among Aβ+ women, ε4 carriers reported greater anxiety symptoms than non-ε4 carriers (d = 0.83), and female BDNF rs6265 Val66 Met allele carriers reported greater depressive symptoms (d = 0.29).
|
27742526 |
2016 |